Emerging advances in engineered macrophages for tumor immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Emerging advances in engineered macrophages for tumor immunotherapy

Published:2023-03 Issue:3 Volume:25 Page:235-244
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Hu Jing,Yang Qian,Yue Zhongyu,Liao Boting,Cheng Huijuan,Li Wenqi,Zhang Honghua,Wang Shuling,Tian Qingchang

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference119 articles.

1. Present and future of cancer immunotherapy: A tumor microenvironmental perspective;Yu;Oncol Lett,2018

2. A review of cancer immunotherapy toxicity;Kennedy;CA Cancer J Clin,2020

3. Chimeric antigen receptor T cells for sustained remissions in leukemia;Maude;N Engl J Med,2014

4. Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor;Kochenderfer;J Clin Oncol,2015

5. Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy;Komohara;Adv Drug Deliv Rev,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering M1 macrophages with targeting aptamers for enhanced adoptive immunotherapy by modifying the cell surface;Biomedicine & Pharmacotherapy;2024-08

2. The CAR macrophage cells, a novel generation of chimeric antigen-based approach against solid tumors;Biomarker Research;2023-11-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP